Shopping Cart 0
Cart Subtotal
AED 0

Global Flu Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 35819

Details

Summary

Market Overview

The global Flu Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Flu Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Flu Vaccine market has been segmented into Split Influenza Vaccine, Pandemic Influenza Vaccine, Subunit Influenza Vaccine, Quadrivalent Influenza Vaccine, etc.

By Application, Flu Vaccine has been segmented into For Children (6 months to 3 years), For Adults and Children over 3 years, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Flu Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Flu Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Flu Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Flu Vaccine market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Flu Vaccine markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.

Competitive Landscape and Flu Vaccine Market Share Analysis

Flu Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Flu Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Flu Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Flu Vaccine are: Hualan Bio, Changsheng Biological, SANOFI, CCBIO, SINOVAC, Aleph Biomedical, GSK, ZYAK, Adimmune, SIOBP, Aimei Hissen, Tianyuan Bio-pharma(Novartis), Simcere Vaxtec, etc. Among other players domestic and global, Flu Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Flu Vaccine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Flu Vaccine, with price, sales, revenue and global market share of Flu Vaccine in 2018 and 2019.

Chapter 3, the Flu Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Flu Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Flu Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Flu Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Flu Vaccine Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Split Influenza Vaccine

1.2.3 Pandemic Influenza Vaccine

1.2.4 Subunit Influenza Vaccine

1.2.5 Quadrivalent Influenza Vaccine

1.3 Market Analysis by Application

1.3.1 Overview: Global Flu Vaccine Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 For Children (6 months to 3 years)

1.3.3 For Adults and Children over 3 years

1.4 Overview of Global Flu Vaccine Market

1.4.1 Global Flu Vaccine Market Status and Outlook (2015-2025)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Hualan Bio

2.1.1 Hualan Bio Details

2.1.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Hualan Bio SWOT Analysis

2.1.4 Hualan Bio Product and Services

2.1.5 Hualan Bio Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Changsheng Biological

2.2.1 Changsheng Biological Details

2.2.2 Changsheng Biological Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Changsheng Biological SWOT Analysis

2.2.4 Changsheng Biological Product and Services

2.2.5 Changsheng Biological Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 SANOFI

2.3.1 SANOFI Details

2.3.2 SANOFI Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 SANOFI SWOT Analysis

2.3.4 SANOFI Product and Services

2.3.5 SANOFI Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 CCBIO

2.4.1 CCBIO Details

2.4.2 CCBIO Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 CCBIO SWOT Analysis

2.4.4 CCBIO Product and Services

2.4.5 CCBIO Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 SINOVAC

2.5.1 SINOVAC Details

2.5.2 SINOVAC Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 SINOVAC SWOT Analysis

2.5.4 SINOVAC Product and Services

2.5.5 SINOVAC Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Aleph Biomedical

2.6.1 Aleph Biomedical Details

2.6.2 Aleph Biomedical Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Aleph Biomedical SWOT Analysis

2.6.4 Aleph Biomedical Product and Services

2.6.5 Aleph Biomedical Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 GSK

2.7.1 GSK Details

2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 GSK SWOT Analysis

2.7.4 GSK Product and Services

2.7.5 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 ZYAK

2.8.1 ZYAK Details

2.8.2 ZYAK Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 ZYAK SWOT Analysis

2.8.4 ZYAK Product and Services

2.8.5 ZYAK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Adimmune

2.9.1 Adimmune Details

2.9.2 Adimmune Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Adimmune SWOT Analysis

2.9.4 Adimmune Product and Services

2.9.5 Adimmune Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 SIOBP

2.10.1 SIOBP Details

2.10.2 SIOBP Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 SIOBP SWOT Analysis

2.10.4 SIOBP Product and Services

2.10.5 SIOBP Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.11 Aimei Hissen

2.11.1 Aimei Hissen Details

2.11.2 Aimei Hissen Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Aimei Hissen SWOT Analysis

2.11.4 Aimei Hissen Product and Services

2.11.5 Aimei Hissen Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.12 Tianyuan Bio-pharma(Novartis)

2.12.1 Tianyuan Bio-pharma(Novartis) Details

2.12.2 Tianyuan Bio-pharma(Novartis) Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Tianyuan Bio-pharma(Novartis) SWOT Analysis

2.12.4 Tianyuan Bio-pharma(Novartis) Product and Services

2.12.5 Tianyuan Bio-pharma(Novartis) Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.13 Simcere Vaxtec

2.13.1 Simcere Vaxtec Details

2.13.2 Simcere Vaxtec Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Simcere Vaxtec SWOT Analysis

2.13.4 Simcere Vaxtec Product and Services

2.13.5 Simcere Vaxtec Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Flu Vaccine Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Flu Vaccine Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Flu Vaccine Manufacturer Market Share in 2019

3.3.2 Top 6 Flu Vaccine Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Flu Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Flu Vaccine Sales and Market Share by Regions (2015-2020)

4.1.2 Global Flu Vaccine Revenue and Market Share by Regions (2015-2020)

4.2 North America Flu Vaccine Sales and Growth Rate (2015-2020)

4.3 Europe Flu Vaccine Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Flu Vaccine Sales and Growth Rate (2015-2020)

4.5 South America Flu Vaccine Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Flu Vaccine Sales and Growth Rate (2015-2020)

5 North America by Country

5.1 North America Flu Vaccine Sales, Revenue and Market Share by Country

5.1.1 North America Flu Vaccine Sales and Market Share by Country (2015-2020)

5.1.2 North America Flu Vaccine Revenue and Market Share by Country (2015-2020)

5.2 United States Flu Vaccine Sales and Growth Rate (2015-2020)

5.3 Canada Flu Vaccine Sales and Growth Rate (2015-2020)

5.4 Mexico Flu Vaccine Sales and Growth Rate (2015-2020)

6 Europe by Country

6.1 Europe Flu Vaccine Sales, Revenue and Market Share by Country

6.1.1 Europe Flu Vaccine Sales and Market Share by Country (2015-2020)

6.1.2 Europe Flu Vaccine Revenue and Market Share by Country (2015-2020)

6.2 Germany Flu Vaccine Sales and Growth Rate (2015-2020)

6.3 UK Flu Vaccine Sales and Growth Rate (2015-2020)

6.4 France Flu Vaccine Sales and Growth Rate (2015-2020)

6.5 Russia Flu Vaccine Sales and Growth Rate (2015-2020)

6.6 Italy Flu Vaccine Sales and Growth Rate (2015-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Flu Vaccine Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Flu Vaccine Sales and Market Share by Regions (2015-2020)

7.1.2 Asia-Pacific Flu Vaccine Revenue and Market Share by Regions (2015-2020)

7.2 China Flu Vaccine Sales and Growth Rate (2015-2020)

7.3 Japan Flu Vaccine Sales and Growth Rate (2015-2020)

7.4 Korea Flu Vaccine Sales and Growth Rate (2015-2020)

7.5 India Flu Vaccine Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Flu Vaccine Sales and Growth Rate (2015-2020)

7.7 Australia Flu Vaccine Sales and Growth Rate (2015-2020)

8 South America by Country

8.1 South America Flu Vaccine Sales, Revenue and Market Share by Country

8.1.1 South America Flu Vaccine Sales and Market Share by Country (2015-2020)

8.1.2 South America Flu Vaccine Revenue and Market Share by Country (2015-2020)

8.2 Brazil Flu Vaccine Sales and Growth Rate (2015-2020)

8.3 Argentina Flu Vaccine Sales and Growth Rate (2015-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Flu Vaccine Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Flu Vaccine Sales and Market Share by Country (2015-2020)

9.1.2 Middle East & Africa Flu Vaccine Revenue and Market Share by Country (2015-2020)

9.2 Saudi Arabia Flu Vaccine Sales and Growth Rate (2015-2020)

9.3 Turkey Flu Vaccine Sales and Growth Rate (2015-2020)

9.4 Egypt Flu Vaccine Sales and Growth Rate (2015-2020)

9.5 South Africa Flu Vaccine Sales and Growth Rate (2015-2020)

10 Market Segment by Type

10.1 Global Flu Vaccine Sales and Market Share by Type (2015-2020)

10.2 Global Flu Vaccine Revenue and Market Share by Type (2015-2020)

10.3 Global Flu Vaccine Price by Type (2015-2020)

11 Global Flu Vaccine Market Segment by Application

11.1 Global Flu Vaccine Sales Market Share by Application (2015-2020)

11.2 Global Flu Vaccine Revenue Market Share by Application (2015-2020)

11.3 Global Flu Vaccine Price by Application (2015-2020)

12 Market Forecast

12.1 Global Flu Vaccine Sales, Revenue and Growth Rate (2021-2025)

12.2 Flu Vaccine Market Forecast by Regions (2021-2025)

12.2.1 North America Flu Vaccine Market Forecast (2021-2025)

12.2.2 Europe Flu Vaccine Market Forecast (2021-2025)

12.2.3 Asia-Pacific Flu Vaccine Market Forecast (2021-2025)

12.2.4 South America Flu Vaccine Market Forecast (2021-2025)

12.2.5 Middle East & Africa Flu Vaccine Market Forecast (2021-2025)

12.3 Flu Vaccine Market Forecast by Type (2021-2025)

12.3.1 Global Flu Vaccine Sales Forecast by Type (2021-2025)

12.3.2 Global Flu Vaccine Market Share Forecast by Type (2021-2025)

12.4 Flu Vaccine Market Forecast by Application (2021-2025)

12.4.1 Global Flu Vaccine Sales Forecast by Application (2021-2025)

12.4.2 Global Flu Vaccine Market Share Forecast by Application (2021-2025)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About US


List Of Figure

List of Tables

Table 1. Global Flu Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Flu Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Market Opportunities in Next Few Years

Table 5. Market Risks Analysis

Table 6. Market Drivers

Table 7. Hualan Bio Basic Information, Manufacturing Base and Competitors

Table 8. Hualan Bio Flu Vaccine Major Business

Table 9. Hualan Bio Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 10. Hualan Bio SWOT Analysis

Table 11. Hualan Bio Flu Vaccine Product and Services

Table 12. Hualan Bio Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 13. Changsheng Biological Basic Information, Manufacturing Base and Competitors

Table 14. Changsheng Biological Flu Vaccine Major Business

Table 15. Changsheng Biological Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 16. Changsheng Biological SWOT Analysis

Table 17. Changsheng Biological Flu Vaccine Product and Services

Table 18. Changsheng Biological Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 19. SANOFI Basic Information, Manufacturing Base and Competitors

Table 20. SANOFI Flu Vaccine Major Business

Table 21. SANOFI Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 22. SANOFI SWOT Analysis

Table 23. SANOFI Flu Vaccine Product and Services

Table 24. SANOFI Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 25. CCBIO Basic Information, Manufacturing Base and Competitors

Table 26. CCBIO Flu Vaccine Major Business

Table 27. CCBIO Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 28. CCBIO SWOT Analysis

Table 29. CCBIO Flu Vaccine Product and Services

Table 30. CCBIO Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 31. SINOVAC Basic Information, Manufacturing Base and Competitors

Table 32. SINOVAC Flu Vaccine Major Business

Table 33. SINOVAC Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 34. SINOVAC SWOT Analysis

Table 35. SINOVAC Flu Vaccine Product and Services

Table 36. SINOVAC Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 37. Aleph Biomedical Basic Information, Manufacturing Base and Competitors

Table 38. Aleph Biomedical Flu Vaccine Major Business

Table 39. Aleph Biomedical Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 40. Aleph Biomedical SWOT Analysis

Table 41. Aleph Biomedical Flu Vaccine Product and Services

Table 42. Aleph Biomedical Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 43. GSK Basic Information, Manufacturing Base and Competitors

Table 44. GSK Flu Vaccine Major Business

Table 45. GSK Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 46. GSK SWOT Analysis

Table 47. GSK Flu Vaccine Product and Services

Table 48. GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 49. ZYAK Basic Information, Manufacturing Base and Competitors

Table 50. ZYAK Flu Vaccine Major Business

Table 51. ZYAK Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 52. ZYAK SWOT Analysis

Table 53. ZYAK Flu Vaccine Product and Services

Table 54. ZYAK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 55. Adimmune Basic Information, Manufacturing Base and Competitors

Table 56. Adimmune Flu Vaccine Major Business

Table 57. Adimmune Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 58. Adimmune SWOT Analysis

Table 59. Adimmune Flu Vaccine Product and Services

Table 60. Adimmune Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 61. SIOBP Basic Information, Manufacturing Base and Competitors

Table 62. SIOBP Flu Vaccine Major Business

Table 63. SIOBP Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 64. SIOBP SWOT Analysis

Table 65. SIOBP Flu Vaccine Product and Services

Table 66. SIOBP Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 67. Aimei Hissen Basic Information, Manufacturing Base and Competitors

Table 68. Aimei Hissen Flu Vaccine Major Business

Table 69. Aimei Hissen Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 70. Aimei Hissen SWOT Analysis

Table 71. Aimei Hissen Flu Vaccine Product and Services

Table 72. Aimei Hissen Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 73. Tianyuan Bio-pharma(Novartis) Basic Information, Manufacturing Base and Competitors

Table 74. Tianyuan Bio-pharma(Novartis) Flu Vaccine Major Business

Table 75. Tianyuan Bio-pharma(Novartis) Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 76. Tianyuan Bio-pharma(Novartis) SWOT Analysis

Table 77. Tianyuan Bio-pharma(Novartis) Flu Vaccine Product and Services

Table 78. Tianyuan Bio-pharma(Novartis) Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 79. Simcere Vaxtec Basic Information, Manufacturing Base and Competitors

Table 80. Simcere Vaxtec Flu Vaccine Major Business

Table 81. Simcere Vaxtec Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 82. Simcere Vaxtec SWOT Analysis

Table 83. Simcere Vaxtec Flu Vaccine Product and Services

Table 84. Simcere Vaxtec Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 85. Global Flu Vaccine Sales by Manufacturer (2018-2019) (K Doses)

Table 86. Global Flu Vaccine Revenue by Manufacturer (2018-2019) (USD Million)

Table 87. Global Flu Vaccine Sales by Regions (2015-2020) (K Doses)

Table 88. Global Flu Vaccine Sales Market Share by Regions (2015-2020)

Table 89. Global Flu Vaccine Revenue by Regions (2015-2020) (USD Million)

Table 90. North America Flu Vaccine Sales by Countries (2015-2020) (K Doses)

Table 91. North America Flu Vaccine Sales Market Share by Countries (2015-2020)

Table 92. North America Flu Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 93. North America Flu Vaccine Revenue Market Share by Countries (2015-2020)

Table 94. Europe Flu Vaccine Sales by Countries (2015-2020) (K Doses)

Table 95. Europe Flu Vaccine Sales Market Share by Countries (2015-2020)

Table 96. Europe Flu Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 97. Asia-Pacific Flu Vaccine Sales by Regions (2015-2020) (K Doses)

Table 98. Asia-Pacific Flu Vaccine Sales Market Share by Regions (2015-2020)

Table 99. Asia-Pacific Flu Vaccine Revenue by Regions (2015-2020) (USD Million)

Table 100. South America Flu Vaccine Sales by Countries (2015-2020) (K Doses)

Table 101. South America Flu Vaccine Sales Market Share by Countries (2015-2020)

Table 102. South America Flu Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 103. South America Flu Vaccine Revenue Market Share by Countries (2015-2020)

Table 104. Middle East & Africa Flu Vaccine Sales by Countries (2015-2020) (K Doses)

Table 105. Middle East & Africa Flu Vaccine Sales Market Share by Countries (2015-2020)

Table 106. Middle East & Africa Flu Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 107. Middle East & Africa Flu Vaccine Revenue Market Share by Countries (2015-2020)

Table 108. Global Flu Vaccine Sales by Type (2015-2020) (K Doses)

Table 109. Global Flu Vaccine Sales Share by Type (2015-2020)

Table 110. Global Flu Vaccine Revenue by Type (2015-2020) (USD Million)

Table 111. Global Flu Vaccine Revenue Share by Type (2015-2020)

Table 112. Global Flu Vaccine Sales by Application (2015-2020) (K Doses)

Table 113. Global Flu Vaccine Sales Share by Application (2015-2020)

Table 114. Global Flu Vaccine Sales Forecast by Regions (2021-2025) (K Doses)

Table 115. Global Flu Vaccine Market Share Forecast by Regions (2021-2025)

Table 116. Global Flu Vaccine Sales Forecast by Type (2021-2025) (K Doses)

Table 117. Global Flu Vaccine Market Share Forecast by Type (2021-2025)

Table 118. Global Flu Vaccine Sales Forecast by Application (2021-2025)

Table 119. Global Flu Vaccine Market Share Forecast by Application (2021-2025)

Table 120. Direct Channel Pros & Cons

Table 121. Indirect Channel Pros & Cons

Table 122. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Flu Vaccine Picture

Figure 2. Global Sales Market Share of Flu Vaccine by Type in 2019

Figure 3. Split Influenza Vaccine Picture

Figure 4. Pandemic Influenza Vaccine Picture

Figure 5. Subunit Influenza Vaccine Picture

Figure 6. Quadrivalent Influenza Vaccine Picture

Figure 7. Flu Vaccine Sales Market Share by Application in 2018

Figure 8. For Children (6 months to 3 years) Picture

Figure 9. For Adults and Children over 3 years Picture

Figure 10. Global Flu Vaccine Market Status and Outlook (2015-2025) (USD Million)

Figure 11. United States Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 12. Canada Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 13. Mexico Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 14. Germany Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 15. France Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 16. UK Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 17. Russia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 18. Italy Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 19. China Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 20. Japan Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 21. Korea Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 22. India Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 23. Southeast Asia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 24. Australia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)

Figure 25. Brazil Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 26. Egypt Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 27. Saudi Arabia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 28. South Africa Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 29. Turkey Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 30. Global Flu Vaccine Sales Market Share by Manufacturer in 2019

Figure 31. Global Flu Vaccine Revenue Market Share by Manufacturer in 2019

Figure 32. Top 3 Flu Vaccine Manufacturer (Revenue) Market Share in 2019

Figure 33. Top 6 Flu Vaccine Manufacturer (Revenue) Market Share in 2019

Figure 34. Key Manufacturer Market Share Trend

Figure 35. Global Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 36. Global Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 37. Global Flu Vaccine Revenue Market Share by Regions (2015-2020)

Figure 38. Global Flu Vaccine Revenue Market Share by Regions in 2018

Figure 39. North America Flu Vaccine Sales and Growth Rate (2015-2020)

Figure 40. Europe Flu Vaccine Sales and Growth Rate (2015-2020)

Figure 41. Asia-Pacific Flu Vaccine Sales and Growth Rate (2015-2020)

Figure 42. South America Flu Vaccine Sales and Growth Rate (2015-2020)

Figure 43. Middle East & Africa Flu Vaccine Sales and Growth Rate (2015-2020)

Figure 44. North America Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 45. North America Flu Vaccine Sales Market Share by Countries (2015-2020)

Figure 46. North America Flu Vaccine Sales Market Share by Countries in 2018

Figure 47. North America Flu Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)

Figure 48. North America Flu Vaccine Revenue Market Share by Countries in 2018

Figure 49. United States Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 50. Canada Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 51. Mexico Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 52. Europe Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 53. Europe Flu Vaccine Revenue Market Share by Countries (2015-2020)

Figure 54. Europe Flu Vaccine Revenue Market Share by Countries in 2019

Figure 55. Germany Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 56. UK Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 57. France Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 58. Russia Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 59. Italy Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 60. Asia-Pacific Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 61. Asia-Pacific Flu Vaccine Sales Market Share by Regions 2019

Figure 62. Asia-Pacific Flu Vaccine Revenue Market Share by Regions 2019

Figure 63. China Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 64. Japan Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 65. Korea Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 66. India Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 67. Southeast Asia Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 68. South America Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 69. South America Flu Vaccine Sales Market Share by Countries in 2019

Figure 70. South America Flu Vaccine Revenue Market Share by Countries in 2019

Figure 71. Brazil Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 72. Argentina Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 73. Middle East and Africa Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 74. Middle East and Africa Flu Vaccine Sales Market Share by Countries in 2019

Figure 75. Middle East and Africa Flu Vaccine Revenue Market Share by Countries (2015-2020)

Figure 76. Middle East and Africa Flu Vaccine Revenue Market Share by Countries in 2019

Figure 77. Saudi Arabia Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 78. Egypt Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 79. Turkey Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 80. South Africa Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 81. Global Flu Vaccine Sales and Growth Rate (2021-2025) (K Doses)

Figure 82. Global Flu Vaccine Revenue and Growth Rate (2021-2025) (USD Million)

Figure 83. North America Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)

Figure 84. Europe Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)

Figure 85. Asia-Pacific Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)

Figure 86. South America Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)

Figure 87. Middle East & Africa Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)

Figure 88. Sales Channel: Direct Channel vs Indirect Channel

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Market Overview

The global Flu Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Flu Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Flu Vaccine market has been segmented into Split Influenza Vaccine, Pandemic Influenza Vaccine, Subunit Influenza Vaccine, Quadrivalent Influenza Vaccine, etc.

By Application, Flu Vaccine has been segmented into For Children (6 months to 3 years), For Adults and Children over 3 years, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Flu Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Flu Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Flu Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Flu Vaccine market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Flu Vaccine markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.

Competitive Landscape and Flu Vaccine Market Share Analysis

Flu Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Flu Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Flu Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Flu Vaccine are: Hualan Bio, Changsheng Biological, SANOFI, CCBIO, SINOVAC, Aleph Biomedical, GSK, ZYAK, Adimmune, SIOBP, Aimei Hissen, Tianyuan Bio-pharma(Novartis), Simcere Vaxtec, etc. Among other players domestic and global, Flu Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Flu Vaccine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Flu Vaccine, with price, sales, revenue and global market share of Flu Vaccine in 2018 and 2019.

Chapter 3, the Flu Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Flu Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Flu Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Flu Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Flu Vaccine Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Split Influenza Vaccine

1.2.3 Pandemic Influenza Vaccine

1.2.4 Subunit Influenza Vaccine

1.2.5 Quadrivalent Influenza Vaccine

1.3 Market Analysis by Application

1.3.1 Overview: Global Flu Vaccine Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 For Children (6 months to 3 years)

1.3.3 For Adults and Children over 3 years

1.4 Overview of Global Flu Vaccine Market

1.4.1 Global Flu Vaccine Market Status and Outlook (2015-2025)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Hualan Bio

2.1.1 Hualan Bio Details

2.1.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Hualan Bio SWOT Analysis

2.1.4 Hualan Bio Product and Services

2.1.5 Hualan Bio Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Changsheng Biological

2.2.1 Changsheng Biological Details

2.2.2 Changsheng Biological Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Changsheng Biological SWOT Analysis

2.2.4 Changsheng Biological Product and Services

2.2.5 Changsheng Biological Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 SANOFI

2.3.1 SANOFI Details

2.3.2 SANOFI Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 SANOFI SWOT Analysis

2.3.4 SANOFI Product and Services

2.3.5 SANOFI Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 CCBIO

2.4.1 CCBIO Details

2.4.2 CCBIO Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 CCBIO SWOT Analysis

2.4.4 CCBIO Product and Services

2.4.5 CCBIO Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 SINOVAC

2.5.1 SINOVAC Details

2.5.2 SINOVAC Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 SINOVAC SWOT Analysis

2.5.4 SINOVAC Product and Services

2.5.5 SINOVAC Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Aleph Biomedical

2.6.1 Aleph Biomedical Details

2.6.2 Aleph Biomedical Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Aleph Biomedical SWOT Analysis

2.6.4 Aleph Biomedical Product and Services

2.6.5 Aleph Biomedical Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 GSK

2.7.1 GSK Details

2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 GSK SWOT Analysis

2.7.4 GSK Product and Services

2.7.5 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 ZYAK

2.8.1 ZYAK Details

2.8.2 ZYAK Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 ZYAK SWOT Analysis

2.8.4 ZYAK Product and Services

2.8.5 ZYAK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Adimmune

2.9.1 Adimmune Details

2.9.2 Adimmune Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Adimmune SWOT Analysis

2.9.4 Adimmune Product and Services

2.9.5 Adimmune Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 SIOBP

2.10.1 SIOBP Details

2.10.2 SIOBP Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 SIOBP SWOT Analysis

2.10.4 SIOBP Product and Services

2.10.5 SIOBP Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.11 Aimei Hissen

2.11.1 Aimei Hissen Details

2.11.2 Aimei Hissen Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Aimei Hissen SWOT Analysis

2.11.4 Aimei Hissen Product and Services

2.11.5 Aimei Hissen Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.12 Tianyuan Bio-pharma(Novartis)

2.12.1 Tianyuan Bio-pharma(Novartis) Details

2.12.2 Tianyuan Bio-pharma(Novartis) Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Tianyuan Bio-pharma(Novartis) SWOT Analysis

2.12.4 Tianyuan Bio-pharma(Novartis) Product and Services

2.12.5 Tianyuan Bio-pharma(Novartis) Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.13 Simcere Vaxtec

2.13.1 Simcere Vaxtec Details

2.13.2 Simcere Vaxtec Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Simcere Vaxtec SWOT Analysis

2.13.4 Simcere Vaxtec Product and Services

2.13.5 Simcere Vaxtec Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Flu Vaccine Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Flu Vaccine Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Flu Vaccine Manufacturer Market Share in 2019

3.3.2 Top 6 Flu Vaccine Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Flu Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Flu Vaccine Sales and Market Share by Regions (2015-2020)

4.1.2 Global Flu Vaccine Revenue and Market Share by Regions (2015-2020)

4.2 North America Flu Vaccine Sales and Growth Rate (2015-2020)

4.3 Europe Flu Vaccine Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Flu Vaccine Sales and Growth Rate (2015-2020)

4.5 South America Flu Vaccine Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Flu Vaccine Sales and Growth Rate (2015-2020)

5 North America by Country

5.1 North America Flu Vaccine Sales, Revenue and Market Share by Country

5.1.1 North America Flu Vaccine Sales and Market Share by Country (2015-2020)

5.1.2 North America Flu Vaccine Revenue and Market Share by Country (2015-2020)

5.2 United States Flu Vaccine Sales and Growth Rate (2015-2020)

5.3 Canada Flu Vaccine Sales and Growth Rate (2015-2020)

5.4 Mexico Flu Vaccine Sales and Growth Rate (2015-2020)

6 Europe by Country

6.1 Europe Flu Vaccine Sales, Revenue and Market Share by Country

6.1.1 Europe Flu Vaccine Sales and Market Share by Country (2015-2020)

6.1.2 Europe Flu Vaccine Revenue and Market Share by Country (2015-2020)

6.2 Germany Flu Vaccine Sales and Growth Rate (2015-2020)

6.3 UK Flu Vaccine Sales and Growth Rate (2015-2020)

6.4 France Flu Vaccine Sales and Growth Rate (2015-2020)

6.5 Russia Flu Vaccine Sales and Growth Rate (2015-2020)

6.6 Italy Flu Vaccine Sales and Growth Rate (2015-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Flu Vaccine Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Flu Vaccine Sales and Market Share by Regions (2015-2020)

7.1.2 Asia-Pacific Flu Vaccine Revenue and Market Share by Regions (2015-2020)

7.2 China Flu Vaccine Sales and Growth Rate (2015-2020)

7.3 Japan Flu Vaccine Sales and Growth Rate (2015-2020)

7.4 Korea Flu Vaccine Sales and Growth Rate (2015-2020)

7.5 India Flu Vaccine Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Flu Vaccine Sales and Growth Rate (2015-2020)

7.7 Australia Flu Vaccine Sales and Growth Rate (2015-2020)

8 South America by Country

8.1 South America Flu Vaccine Sales, Revenue and Market Share by Country

8.1.1 South America Flu Vaccine Sales and Market Share by Country (2015-2020)

8.1.2 South America Flu Vaccine Revenue and Market Share by Country (2015-2020)

8.2 Brazil Flu Vaccine Sales and Growth Rate (2015-2020)

8.3 Argentina Flu Vaccine Sales and Growth Rate (2015-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Flu Vaccine Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Flu Vaccine Sales and Market Share by Country (2015-2020)

9.1.2 Middle East & Africa Flu Vaccine Revenue and Market Share by Country (2015-2020)

9.2 Saudi Arabia Flu Vaccine Sales and Growth Rate (2015-2020)

9.3 Turkey Flu Vaccine Sales and Growth Rate (2015-2020)

9.4 Egypt Flu Vaccine Sales and Growth Rate (2015-2020)

9.5 South Africa Flu Vaccine Sales and Growth Rate (2015-2020)

10 Market Segment by Type

10.1 Global Flu Vaccine Sales and Market Share by Type (2015-2020)

10.2 Global Flu Vaccine Revenue and Market Share by Type (2015-2020)

10.3 Global Flu Vaccine Price by Type (2015-2020)

11 Global Flu Vaccine Market Segment by Application

11.1 Global Flu Vaccine Sales Market Share by Application (2015-2020)

11.2 Global Flu Vaccine Revenue Market Share by Application (2015-2020)

11.3 Global Flu Vaccine Price by Application (2015-2020)

12 Market Forecast

12.1 Global Flu Vaccine Sales, Revenue and Growth Rate (2021-2025)

12.2 Flu Vaccine Market Forecast by Regions (2021-2025)

12.2.1 North America Flu Vaccine Market Forecast (2021-2025)

12.2.2 Europe Flu Vaccine Market Forecast (2021-2025)

12.2.3 Asia-Pacific Flu Vaccine Market Forecast (2021-2025)

12.2.4 South America Flu Vaccine Market Forecast (2021-2025)

12.2.5 Middle East & Africa Flu Vaccine Market Forecast (2021-2025)

12.3 Flu Vaccine Market Forecast by Type (2021-2025)

12.3.1 Global Flu Vaccine Sales Forecast by Type (2021-2025)

12.3.2 Global Flu Vaccine Market Share Forecast by Type (2021-2025)

12.4 Flu Vaccine Market Forecast by Application (2021-2025)

12.4.1 Global Flu Vaccine Sales Forecast by Application (2021-2025)

12.4.2 Global Flu Vaccine Market Share Forecast by Application (2021-2025)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About US


List Of Figure

List of Tables

Table 1. Global Flu Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Flu Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Market Opportunities in Next Few Years

Table 5. Market Risks Analysis

Table 6. Market Drivers

Table 7. Hualan Bio Basic Information, Manufacturing Base and Competitors

Table 8. Hualan Bio Flu Vaccine Major Business

Table 9. Hualan Bio Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 10. Hualan Bio SWOT Analysis

Table 11. Hualan Bio Flu Vaccine Product and Services

Table 12. Hualan Bio Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 13. Changsheng Biological Basic Information, Manufacturing Base and Competitors

Table 14. Changsheng Biological Flu Vaccine Major Business

Table 15. Changsheng Biological Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 16. Changsheng Biological SWOT Analysis

Table 17. Changsheng Biological Flu Vaccine Product and Services

Table 18. Changsheng Biological Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 19. SANOFI Basic Information, Manufacturing Base and Competitors

Table 20. SANOFI Flu Vaccine Major Business

Table 21. SANOFI Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 22. SANOFI SWOT Analysis

Table 23. SANOFI Flu Vaccine Product and Services

Table 24. SANOFI Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 25. CCBIO Basic Information, Manufacturing Base and Competitors

Table 26. CCBIO Flu Vaccine Major Business

Table 27. CCBIO Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 28. CCBIO SWOT Analysis

Table 29. CCBIO Flu Vaccine Product and Services

Table 30. CCBIO Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 31. SINOVAC Basic Information, Manufacturing Base and Competitors

Table 32. SINOVAC Flu Vaccine Major Business

Table 33. SINOVAC Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 34. SINOVAC SWOT Analysis

Table 35. SINOVAC Flu Vaccine Product and Services

Table 36. SINOVAC Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 37. Aleph Biomedical Basic Information, Manufacturing Base and Competitors

Table 38. Aleph Biomedical Flu Vaccine Major Business

Table 39. Aleph Biomedical Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 40. Aleph Biomedical SWOT Analysis

Table 41. Aleph Biomedical Flu Vaccine Product and Services

Table 42. Aleph Biomedical Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 43. GSK Basic Information, Manufacturing Base and Competitors

Table 44. GSK Flu Vaccine Major Business

Table 45. GSK Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 46. GSK SWOT Analysis

Table 47. GSK Flu Vaccine Product and Services

Table 48. GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 49. ZYAK Basic Information, Manufacturing Base and Competitors

Table 50. ZYAK Flu Vaccine Major Business

Table 51. ZYAK Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 52. ZYAK SWOT Analysis

Table 53. ZYAK Flu Vaccine Product and Services

Table 54. ZYAK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 55. Adimmune Basic Information, Manufacturing Base and Competitors

Table 56. Adimmune Flu Vaccine Major Business

Table 57. Adimmune Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 58. Adimmune SWOT Analysis

Table 59. Adimmune Flu Vaccine Product and Services

Table 60. Adimmune Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 61. SIOBP Basic Information, Manufacturing Base and Competitors

Table 62. SIOBP Flu Vaccine Major Business

Table 63. SIOBP Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 64. SIOBP SWOT Analysis

Table 65. SIOBP Flu Vaccine Product and Services

Table 66. SIOBP Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 67. Aimei Hissen Basic Information, Manufacturing Base and Competitors

Table 68. Aimei Hissen Flu Vaccine Major Business

Table 69. Aimei Hissen Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 70. Aimei Hissen SWOT Analysis

Table 71. Aimei Hissen Flu Vaccine Product and Services

Table 72. Aimei Hissen Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 73. Tianyuan Bio-pharma(Novartis) Basic Information, Manufacturing Base and Competitors

Table 74. Tianyuan Bio-pharma(Novartis) Flu Vaccine Major Business

Table 75. Tianyuan Bio-pharma(Novartis) Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 76. Tianyuan Bio-pharma(Novartis) SWOT Analysis

Table 77. Tianyuan Bio-pharma(Novartis) Flu Vaccine Product and Services

Table 78. Tianyuan Bio-pharma(Novartis) Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 79. Simcere Vaxtec Basic Information, Manufacturing Base and Competitors

Table 80. Simcere Vaxtec Flu Vaccine Major Business

Table 81. Simcere Vaxtec Flu Vaccine Total Revenue (USD Million) (2017-2018)

Table 82. Simcere Vaxtec SWOT Analysis

Table 83. Simcere Vaxtec Flu Vaccine Product and Services

Table 84. Simcere Vaxtec Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 85. Global Flu Vaccine Sales by Manufacturer (2018-2019) (K Doses)

Table 86. Global Flu Vaccine Revenue by Manufacturer (2018-2019) (USD Million)

Table 87. Global Flu Vaccine Sales by Regions (2015-2020) (K Doses)

Table 88. Global Flu Vaccine Sales Market Share by Regions (2015-2020)

Table 89. Global Flu Vaccine Revenue by Regions (2015-2020) (USD Million)

Table 90. North America Flu Vaccine Sales by Countries (2015-2020) (K Doses)

Table 91. North America Flu Vaccine Sales Market Share by Countries (2015-2020)

Table 92. North America Flu Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 93. North America Flu Vaccine Revenue Market Share by Countries (2015-2020)

Table 94. Europe Flu Vaccine Sales by Countries (2015-2020) (K Doses)

Table 95. Europe Flu Vaccine Sales Market Share by Countries (2015-2020)

Table 96. Europe Flu Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 97. Asia-Pacific Flu Vaccine Sales by Regions (2015-2020) (K Doses)

Table 98. Asia-Pacific Flu Vaccine Sales Market Share by Regions (2015-2020)

Table 99. Asia-Pacific Flu Vaccine Revenue by Regions (2015-2020) (USD Million)

Table 100. South America Flu Vaccine Sales by Countries (2015-2020) (K Doses)

Table 101. South America Flu Vaccine Sales Market Share by Countries (2015-2020)

Table 102. South America Flu Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 103. South America Flu Vaccine Revenue Market Share by Countries (2015-2020)

Table 104. Middle East & Africa Flu Vaccine Sales by Countries (2015-2020) (K Doses)

Table 105. Middle East & Africa Flu Vaccine Sales Market Share by Countries (2015-2020)

Table 106. Middle East & Africa Flu Vaccine Revenue by Countries (2015-2020) (USD Million)

Table 107. Middle East & Africa Flu Vaccine Revenue Market Share by Countries (2015-2020)

Table 108. Global Flu Vaccine Sales by Type (2015-2020) (K Doses)

Table 109. Global Flu Vaccine Sales Share by Type (2015-2020)

Table 110. Global Flu Vaccine Revenue by Type (2015-2020) (USD Million)

Table 111. Global Flu Vaccine Revenue Share by Type (2015-2020)

Table 112. Global Flu Vaccine Sales by Application (2015-2020) (K Doses)

Table 113. Global Flu Vaccine Sales Share by Application (2015-2020)

Table 114. Global Flu Vaccine Sales Forecast by Regions (2021-2025) (K Doses)

Table 115. Global Flu Vaccine Market Share Forecast by Regions (2021-2025)

Table 116. Global Flu Vaccine Sales Forecast by Type (2021-2025) (K Doses)

Table 117. Global Flu Vaccine Market Share Forecast by Type (2021-2025)

Table 118. Global Flu Vaccine Sales Forecast by Application (2021-2025)

Table 119. Global Flu Vaccine Market Share Forecast by Application (2021-2025)

Table 120. Direct Channel Pros & Cons

Table 121. Indirect Channel Pros & Cons

Table 122. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Flu Vaccine Picture

Figure 2. Global Sales Market Share of Flu Vaccine by Type in 2019

Figure 3. Split Influenza Vaccine Picture

Figure 4. Pandemic Influenza Vaccine Picture

Figure 5. Subunit Influenza Vaccine Picture

Figure 6. Quadrivalent Influenza Vaccine Picture

Figure 7. Flu Vaccine Sales Market Share by Application in 2018

Figure 8. For Children (6 months to 3 years) Picture

Figure 9. For Adults and Children over 3 years Picture

Figure 10. Global Flu Vaccine Market Status and Outlook (2015-2025) (USD Million)

Figure 11. United States Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 12. Canada Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 13. Mexico Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 14. Germany Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 15. France Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 16. UK Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 17. Russia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 18. Italy Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 19. China Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 20. Japan Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 21. Korea Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 22. India Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 23. Southeast Asia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 24. Australia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)

Figure 25. Brazil Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 26. Egypt Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 27. Saudi Arabia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 28. South Africa Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 29. Turkey Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)

Figure 30. Global Flu Vaccine Sales Market Share by Manufacturer in 2019

Figure 31. Global Flu Vaccine Revenue Market Share by Manufacturer in 2019

Figure 32. Top 3 Flu Vaccine Manufacturer (Revenue) Market Share in 2019

Figure 33. Top 6 Flu Vaccine Manufacturer (Revenue) Market Share in 2019

Figure 34. Key Manufacturer Market Share Trend

Figure 35. Global Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 36. Global Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 37. Global Flu Vaccine Revenue Market Share by Regions (2015-2020)

Figure 38. Global Flu Vaccine Revenue Market Share by Regions in 2018

Figure 39. North America Flu Vaccine Sales and Growth Rate (2015-2020)

Figure 40. Europe Flu Vaccine Sales and Growth Rate (2015-2020)

Figure 41. Asia-Pacific Flu Vaccine Sales and Growth Rate (2015-2020)

Figure 42. South America Flu Vaccine Sales and Growth Rate (2015-2020)

Figure 43. Middle East & Africa Flu Vaccine Sales and Growth Rate (2015-2020)

Figure 44. North America Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 45. North America Flu Vaccine Sales Market Share by Countries (2015-2020)

Figure 46. North America Flu Vaccine Sales Market Share by Countries in 2018

Figure 47. North America Flu Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)

Figure 48. North America Flu Vaccine Revenue Market Share by Countries in 2018

Figure 49. United States Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 50. Canada Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 51. Mexico Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 52. Europe Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 53. Europe Flu Vaccine Revenue Market Share by Countries (2015-2020)

Figure 54. Europe Flu Vaccine Revenue Market Share by Countries in 2019

Figure 55. Germany Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 56. UK Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 57. France Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 58. Russia Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 59. Italy Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 60. Asia-Pacific Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 61. Asia-Pacific Flu Vaccine Sales Market Share by Regions 2019

Figure 62. Asia-Pacific Flu Vaccine Revenue Market Share by Regions 2019

Figure 63. China Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 64. Japan Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 65. Korea Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 66. India Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 67. Southeast Asia Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 68. South America Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 69. South America Flu Vaccine Sales Market Share by Countries in 2019

Figure 70. South America Flu Vaccine Revenue Market Share by Countries in 2019

Figure 71. Brazil Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 72. Argentina Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 73. Middle East and Africa Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)

Figure 74. Middle East and Africa Flu Vaccine Sales Market Share by Countries in 2019

Figure 75. Middle East and Africa Flu Vaccine Revenue Market Share by Countries (2015-2020)

Figure 76. Middle East and Africa Flu Vaccine Revenue Market Share by Countries in 2019

Figure 77. Saudi Arabia Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 78. Egypt Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 79. Turkey Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 80. South Africa Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)

Figure 81. Global Flu Vaccine Sales and Growth Rate (2021-2025) (K Doses)

Figure 82. Global Flu Vaccine Revenue and Growth Rate (2021-2025) (USD Million)

Figure 83. North America Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)

Figure 84. Europe Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)

Figure 85. Asia-Pacific Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)

Figure 86. South America Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)

Figure 87. Middle East & Africa Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)

Figure 88. Sales Channel: Direct Channel vs Indirect Channel

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS